RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.54B
AUM Growth
+$235M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$75.7M
2
+$73.8M
3
+$48.2M
4
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$44M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
+$24.4M

Top Sells

1
+$127M
2
+$13.3M
3
+$9.37M
4
VKTX icon
Viking Therapeutics
VKTX
+$8.87M
5
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$6.72M

Sector Composition

1 Healthcare 92.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$3.28M 0.21%
33,437
27
$1.74M 0.11%
40,000
28
– –
-68,656
29
– –
-496,071
30
– –
-14,275
31
– –
-2,029,396
32
– –
-70,613
33
– –
-1,028,289
34
– –
-56,951
35
– –
-363,636
1
2